Pluvicto CA 1000 MBq/ml, Injektions-/Infusionslösung
7680690270018
CH-69027
Injektions-/Infusionslösung
Associated product:
PLUVICTO CA sol inj 1000 MBq/ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektions-/Infusionslösung
- Galenic group
- Unknown
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1000.0 MBQ | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.1 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69027
- Drug name
- Pluvicto CA, Injektions-/Infusionslösung
- Galenic form
- LSIN
- ATC Code
- V10XX05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 24/02/2023
- Authorization expiration date
- 23/02/2028
- IT Number
- 17.02.
- Domain
- Human medicine
Package details
- Description (FR)
- PLUVICTO CA sol inj 1000 MBq/ml flac
- Description (DE)
- PLUVICTO CA Inj Lös 1000 MBq/ml Durchstf
- Market launch
- 24/02/2023
- Narcotic (BTM)
- No